Cited by 1,558SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Spike mutation D614G alters SARS-CoV-2 fitness

Open access

Plante, Jessica A., Liu, Yang, Liu, Jianying, Xia, Hongjie, Johnson, Bryan A., Lokugamage, Kumari G., Zhang, Xianwen, Muruato, Antonio E., Zou, Jing, Fontes-Garfias, Camila R., Mirchandani, Divya, Scharton, Dionna, Bilello, John P., Ku, Zhiqiang, An, Zhiqiang, Kalveram, Birte, Freiberg, Alexander N., Menachery, Vineet D., Xie, Xuping, Plante, Kenneth S., Weaver, Scott C., Shi, Pei-Yong·2021·Nature

DOI 10.1038/s41586-020-2895-3PMC PMC8158177

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein substitution D614G became dominant during the coronavirus disease 2019 (COVID-19) pandemic 1,2. However, the effect of this variant on viral spread and vaccine efficacy remains to be defined. Here we engineered the spike D614G substitution in the USA-WA1/2020 SARS-CoV-2 strain, and found that it enhances viral replication in human lung epithelial cells and primary human airway tissues by increasing the infectivity and stability of virions. Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs, supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission. Sera from hamsters infected with D614 virus exhibit modestly higher neutralization titres against G614 virus than against D614 virus, suggesting that the mutation is unlikely to reduce the ability of vaccines in clinical trials to protect against COVID-19, and that therapeutic antibodies should be tested against the circulating G614 virus. Together with clinical findings, our work underscores the importance of this variant in viral spread and its implications for vaccine efficacy and antibody therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41586-020-2895-3

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237
The New Statistics: Why and How
Cumming, G. (2014) · Psychological Science · doi:10.1177/0956797613504966 · Cited by 3,200
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
HCA Lung Biological Network, Sungnak, W., Huang, N., Bécavin, C., Berg, M., Queen, R., Litvinukova, M., Talavera-López, C., Maatz, H., Reichart, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0868-6 · Cited by 2,501
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Self-citation
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Hou, Y. J., Okuda, K., Edwards, C. E., Martinez, D. R., Asakura, T., Dinnon, K. H., Kato, T., Lee, R. E., Yount, B. L., Mascenik, T. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.042 · Cited by 1,488

Show all 37 references

Research works printed but not linked: 1

Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020). · DOI · Paper page

Sorted by citations

Items 601–700 of 1,008

Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction
Kim, Y. S., Kwon, E., Kim, B., Chung, H., Choi, G., Kim, Y., & Choi, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012516 · Cited by 21
Targeting an evolutionarily conserved “E-L-L” motif in spike protein to identify a small molecule fusion inhibitor against SARS-CoV-2
Jana, I. D., Bhattacharya, P., Mayilsamy, K., Banerjee, S., Bhattacharje, G., Das, S., Aditya, S., Ghosh, A., McGill, A. R., Srikrishnan, S., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac198 · Cited by 21
Reservoir host immunology and life history shape virulence evolution in zoonotic viruses
Brook, C. E., Rozins, C., Guth, S. E., & Boots, M. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002268 · Cited by 21
COVID-19 outbreak in Malaysia: Decoding D614G mutation of SARS-CoV-2 virus isolated from an asymptomatic case in Pahang
Yassim, A. S. M., Asras, M. F. F., Gazali, A. M., Marcial-Coba, M. S., Zainulabid, U. A., & Ahmad, H. F. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.02.387 · Cited by 20
The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play
Souza, P. F. N., Mesquita, F. P., Amaral, J. L., Landim, P. G. C., Lima, K. R. P., Costa, M. B., Farias, I. R., Lima, L. B., & Montenegro, R. C. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.203 · Cited by 21
Assessing the risk of vaccine-driven virulence evolution in SARS-CoV-2
Miller, I. F., & Metcalf, C. J. E. (2022) · Royal Society Open Science · doi:10.1098/rsos.211021 · Cited by 22
Whole-genome sequencing of SARS-CoV-2 in the Republic of Ireland during waves 1 and 2 of the pandemicPreprint
Mallon, P. W. G., Crispie, F., Gonzalez, G., Tinago, W., Leon, A. A. G., McCabe, M. S., de Barra, E., Yousif, O., Lambert, J. S., Walsh, C. J., et al. (2021) · medRxiv · doi:10.1101/2021.02.09.21251402 · Cited by 19
Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant
Lee, C. Y., Amrun, S. N., Chee, R. S., Goh, Y. S., Mak, T. M., Octavia, S., Yeo, N. K., Chang, Z. W., Tay, M. Z., Torres‐Ruesta, A., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1241 · Cited by 20
COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles?
Mosselhy, D. A., Virtanen, J., Kant, R., He, W. D., Elbahri, M., & Sironen, T. A. (2021) · Nanomaterials · doi:10.3390/nano11030796 · Cited by 20
Reducing SARS-CoV-2 pathological protein activity with small molecules
Pluskota‐Karwatka, D., Hoffmann, M., & Barciszewski, J. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.03.012 · Cited by 18
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR
Amato, L., Jurišić, L., Puglia, I., Lollo, V. D., Curini, V., Torzi, G., Girolamo, A. D., Mangone, I., Mancinelli, A., Decaro, N., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1933609 · Cited by 20
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
Gu, C., Cao, X., Wang, Z., Hu, X., Yao, Y., Zhou, Y., Liu, P., Liu, X., Gao, G., Hu, X., et al. (2021) · mAbs · doi:10.1080/19420862.2021.1930636 · Cited by 20
Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2
Zhang, J., Zhang, Y., Kang, J.-Y., Chen, S., He, Y. O., Han, B., Liu, M., Lu, L., Li, L., Yi, Z., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00282-1 · Cited by 19
Qualitative analysis of a mathematical model with presymptomatic individuals and two SARS-CoV-2 variants
González‐Parra, G., & Arenas, A. J. (2021) · Computational and Applied Mathematics · doi:10.1007/s40314-021-01592-6 · Cited by 20
SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies
Jeda, A. S., Abbassi, S., Mousavizadeh, A., Esghaie, M., Bokharaei‐Salim, F., Jeddi, F., Shafaati, M., & Abdoli, A. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108232 · Cited by 22
Global trends in COVID-19
Zhou, C., Qin, X., Yan, L., Jiang, Y., & Yu, X. (2022) · Infectious Medicine · doi:10.1016/j.imj.2021.08.001 · Cited by 21
Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic
Anwar, M. Z., Lodhi, M. S., Khan, M. T., Khan, M. I., & Sharif, S. (2022) · Genes · doi:10.3390/genes13030552 · Cited by 21
COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
Giau, V. V., Bagyinszky, E., & An, S. S. A. (2022) · Microorganisms · doi:10.3390/microorganisms10030598 · Cited by 21
Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
Ogger, P. P., Martín, M. G., Michalaki, C., Zhou, J., Brown, J. C., Du, Y., Miah, K. M., Habib, O., Hyde, S. C., Gill, D. R., et al. (2022) · European Journal of Immunology · doi:10.1002/eji.202249913 · Cited by 18
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants
Gellenoncourt, S., Saunders, N., Robinot, R., Auguste, L., Rajah, M. M., Kervevan, J., Jeger‐Madiot, R., Staropoli, I., Planchais, C., Mouquet, H., et al. (2022) · Journal of Virology · doi:10.1128/jvi.01301-22 · Cited by 22
The Impact and Progression of the COVID-19 Pandemic in Bulgaria in Its First Two Years
Rangachev, A., Marinov, G. K., & Mladenov, M. (2022) · Vaccines · doi:10.3390/vaccines10111901 · Cited by 20
Structural effects of spike protein D614G mutation in SARS-CoV-2
Dokainish, H., & Sugita, Y. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.11.025 · Cited by 22
An Overview of Repurposed Drugs for Potential COVID-19 Treatment
Govender, K., & Chuturgoon, A. A. (2022) · Antibiotics · doi:10.3390/antibiotics11121678 · Cited by 21
Genomic surveillance of SARS‐CoV‐2 strains circulating in Iran during six waves of the pandemic
Sadeghi, K., Zadheidar, S., Zebardast, A., Nejati, A., Faraji, M., Ghavami, N., Kalantari, S., Salimi, V., Yavarian, J., Abedi, A., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13135 · Cited by 20
Use of a risk assessment tool to determine the origin of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
Chen, X., Kalyar, F., Chughtai, A. A., & MacIntyre, C. R. (2024) · Risk Analysis · doi:10.1111/risa.14291 · Cited by 20
Molecular Analysis of SARS-CoV-2 Genetic Lineages in Jordan: Tracking the Introduction and Spread of COVID-19 UK Variant of Concern at a Country Level
Sallam, M., & Mahafzah, A. M. (2021) · Pathogens · doi:10.3390/pathogens10030302 · Cited by 23
SARS-CoV-2—Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis
Grudlewska‐Buda, K., Wiktorczyk-Kapischke, N., Wałecka-Zacharska, E., Kwiecińska-Piróg, J., Buszko, K., Leis, K., Juszczuk, K., Gospodarek-Komkowska, E., & Skowron, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091962 · Cited by 27
Increased lung cell entry of B.1.617.2 and evasion of antibodies induced by infection and BNT162b2 vaccinationPreprint
Arora, P., Kempf, A. M., Nehlmeier, I., Sidarovich, A., Krüger, N., Graichen, L., Moldenhauer, A.-S., Winkler, M. S., Schulz, S. R., Jäck, H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.23.449568 · Cited by 20
The unique evolutionary dynamics of the SARS-CoV-2 Delta variantPreprint
Stern, A., Fleishon, S., Kustin, T., Dotan, E., Mandelboim, M., Erster, O., Mendelson, E., Mor, O., & Zuckerman, N. S. (2021) · medRxiv · doi:10.1101/2021.08.05.21261642 · Cited by 23
Follow-up investigation and detailed mutational characterization of the SARS-CoV-2 Omicron variant lineages (BA.1, BA.2, BA.3 and BA.1.1)Preprint
Abbas, Q., Викторович, К. А., Sharrouf, K. A., Jyakhwo, S., & Komissarov, A. S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.25.481941 · Cited by 19
Association of SARS-CoV-2 Clades with Clinical, Inflammatory and Virologic Outcomes: An Observational Study
Young, B. E., Wei, W. E., Fong, S., Mak, T. M., Anderson, D. E., Chan, Y., Pung, R., Heng, C. S., Ang, L. W., Zheng, A. K. E., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2021.103319 · Cited by 18
Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence
Wong, L.-Y. R., Zheng, J. H., Sariol, A., Lowery, S. A., Meyerholz, D. K., Gallagher, T., & Perlman, S. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102983118 · Cited by 24
Variantes de SARS-CoV-2, una historia todavía inacabada
Pérez-Abeledo, M., & Moreno, J. C. S. (2021) · Vacunas · doi:10.1016/j.vacun.2021.06.003 · Cited by 20
COVID-19 Infection in Children, Infants and Pregnant Subjects: An Overview of Recent Insights and Therapies
Malcangi, G., Inchingolo, A. D., Inchingolo, A. M., Santacroce, L., Marinelli, G., Mancini, A., Vimercati, L., Maggiore, M. E., D’Oria, M. T., Hazballa, D., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9091964 · Cited by 31
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection
Chaouat, A. E., Achdout, H., Kol, I., Berhani, O., Roi, G., Vitner, E. B., Melamed, S., Politi, B., Zahavy, E., Brizić, I., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010175 · Cited by 20
On the Origins of Omicron’s Unique Spike Gene Insertion
Venkatakrishnan, A., Anand, P., Lenehan, P. J., Suratekar, R., Raghunathan, B., Niesen, M. J. M., & Soundararajan, V. (2022) · Vaccines · doi:10.3390/vaccines10091509 · Cited by 76
Intra-Host Evolution Provides for Continuous Emergence of SARS-CoV-2 Variants
Landis, J. T., Moorad, R., Pluta, L., Caro‐Vegas, C., McNamara, R. P., Eason, A. B., Bailey, A., Villamor, F. C. S., Juarez, A., Wong, J. P., et al. (2021) · mBio · doi:10.1128/mbio.03448-22 · Cited by 20
The E2 glycoprotein holds key residues for Mayaro virus adaptation to the urban Aedes aegypti mosquito
Cereghino, C., Roesch, F., Carrau, L., Hardy, A., Filho, H. V. R., Henrion-Lacritick, A., Koh, C., Marano, J. M., Bates, T. A., Rai, P., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1010491 · Cited by 19
Challenges and Prospects in Developing Future SARS-CoV-2 Vaccines: Overcoming Original Antigenic Sin and Inducing Broadly Neutralizing Antibodies
Evans, J. P., & Liu, S. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300315 · Cited by 19
The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters
Stauft, C. B., Lien, C. Z., Selvaraj, P., Liu, S., & Wang, T. T. (2021) · Virology · doi:10.1016/j.virol.2021.01.005 · Cited by 19
Animal Hosts and Experimental Models of SARS-CoV-2 Infection
Parolin, C., Virtuoso, S., Giovanetti, M., Angeletti, S., Ciccozzi, M., & Borsetti, A. (2021) · Chemotherapy · doi:10.1159/000515341 · Cited by 20
The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro
Lyu, J., Bao, L., Shen, X., Yan, C., Zhang, C., Wei, W., Yang, Y., Li, J., Dong, J., Xiao, L., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107797 · Cited by 20
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model
Cochin, M., Lucıanı, L., Touret, F., Driouich, J., Petit, P.-R., Moureau, G., Baronti, C., Laprie, C., Thirion, L., Maes, P., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03171-9 · Cited by 17
SARS-CoV-2: The Interplay Between Evolution and Host Immunity
Case, J. B., Jain, S., Suthar, M. S., & Diamond, M. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083122-043054 · Cited by 26
Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
Massacci, A., Sperandio, E., D’Ambrosio, L., Maffei, M., Palombo, F., Aurisicchio, L., Ciliberto, G., & Pallocca, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02675-4 · Cited by 17
SARS-CoV-2 complete genome sequencing from the Italian Campania region using a highly automated next generation sequencing system
Rachiglio, A. M., Sabato, L. D., Roma, C., Cennamo, M., Fiorenza, M., Terracciano, D., Pasquale, R., Bergantino, F., Cavalcanti, E., Botti, G., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02912-4 · Cited by 18
Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity
Du, K., Sun, L., Luo, Z., Cao, Y., Sun, Q., Zhang, K., Faizy, A., Piomelli, D., Lu, X., Shan, J., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155181 · Cited by 18
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates
Zhu, D. Y., Gorman, M. J., Yuan, D., Yu, J., Mercado, N. B., McMahan, K., Borducchi, E. N., Lifton, M. A., Liu, J., Nampanya, F., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001609 · Cited by 18
Self-citation
Breakthrough COVID-19 Infections in the US: Implications for Prolonging the Pandemic
Alcendor, D. J., Matthews-Juarez, P., Smoot, D. T., Hildreth, J. E. K., Lamar, K. D., Tabatabai, M., Wilus, D. M., & Juárez, P. D. (2022) · Vaccines · doi:10.3390/vaccines10050755 · Cited by 18
Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling
Frolova, E. I., Palchevska, O., Lukash, T., Domínguez, F. D. B. P., Britt, W. J., & Frolov, I. V. (2022) · Journal of Virology · doi:10.1128/jvi.00753-22 · Cited by 19
Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: From alpha to Omicron
Yu, C. Y., Wong, S. Y., Liew, N. W. C., Joseph, N. M. S., Zakaria, Z., Isa, N. M., Soe, H. J., Kairon, R., Nordin, S. A., & Chee, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1001022 · Cited by 19
SARS-CoV-2 Spike Protein Post-Translational Modification Landscape and Its Impact on Protein Structure and Function via Computational Prediction
Liang, B., Zhu, Y., Shi, W., Ni, C., Tan, B., & Tang, S. (2023) · Research · doi:10.34133/research.0078 · Cited by 17
Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant
Ren, W., Zhang, Y., Rao, J., Wang, Z., Lan, J., Liu, K., Zhang, X., Hu, X., Yang, C., Zhong, G., et al. (2023) · mBio · doi:10.1128/mbio.00416-23 · Cited by 19
Self-citation
Electrochemical Detection of Viral Nucleic Acids by DNA Nanolock-Based Porous Electrode Device
Huang, Z., Wang, W., Wang, Y., Wang, H., Pang, Y., Yuan, Q., Tan, J., & Tan, W. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03168 · Cited by 17
Persistence of SARS‐CoV‐2 infection and viral intra ‐ and inter ‐host evolution in COVID‐19 hospitalized patients
Pavia, G., Quirino, A., Marascio, N., Veneziano, C., Longhini, F., Bruni, A., Garofalo, E., Pantanella, M., Manno, M., Gigliotti, S., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29708 · Cited by 18
Biophysical principles predict fitness of SARS-CoV-2 variants
Wang, D., Huot, M., Mohanty, V., & Shakhnovich, E. I. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314518121 · Cited by 19
C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic
Peter Simmonds, K. (2024) · mBio · doi:10.1128/mbio.02493-24 · Cited by 19
Virion morphology and on-virus spike protein structures of diverse SARS-CoV-2 variants
Ke, Z., Peacock, T. P., Brown, J. C., Sheppard, C., Croll, T. I., Kotecha, A., Goldhill, D. H., Barclay, W., & Briggs, J. A. G. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00303-1 · Cited by 16
Current Update on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development with a Special Emphasis on Gene Therapy Viral Vector Design and Construction for Vaccination
Bişgin, A., Şanlioğlu, A. D., Ekşi, Y. E., Griffith, T. S., & Şanlıoğlu, S. (2021) · Human Gene Therapy · doi:10.1089/hum.2021.052 · Cited by 18
Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage on the Human ACE2 Receptor Binding: A Structural Insight
Khan, M. I., Baig, M. H., Mondal, T., Alorabi, M., Sharma, T., Dong, J.-J., & Choi, Y. (2021) · Viruses · doi:10.3390/v13112295 · Cited by 18
Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19
Cao, J., Liu, Y., Zhou, M., Dong, S., Hou, Y., Jia, X., Lan, X., Zhang, Y., Guo, J., Xiao, G., et al. (2022) · Viruses · doi:10.3390/v14020353 · Cited by 20
Self-citation
Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein
Wolf, K., Kwan, J. C., & Kamil, J. P. (2022) · mBio · doi:10.1128/mbio.02030-21 · Cited by 17
Design of Specific Primer Sets for the Detection of SARS-CoV-2 Variants of Concern B.1.1.7, B.1.351, P.1, B.1.617.2 using Artificial IntelligencePreprint
Perez-Romero, C. A., Tonda, A. P., Mendoza‐Maldonado, L., Coz, E., Tabeling, P., Vanhomwegen, J., Claassen, E., Garssen, J., Kraneveld, A. D., & Lopez‐Rincon, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.20.427043 · Cited by 18
Protection of human ACE2 transgenic Syrian hamsters from SARS CoV-2 variants by human polyclonal IgG from hyper-immunized transchromosomic bovinesPreprint
Gilliland, T. H., Liu, Y., Li, R., Dunn, M., Cottle, E. L., Terada, Y., Ryckman, Z., Alcorn, M. D. H., Vasilatos, S. N., Lundy, J. D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.26.453840 · Cited by 17
Self-citation
Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)
Caza, M., Hogan, C. A., Jassem, A. N., Prystajecky, N., Hadzic, A., & Wilmer, A. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104996 · Cited by 17
A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity
Bellier, B., Saura, A., Luján, L. A., Molina, C. R., Luján, H. D., & Klatzmann, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.837443 · Cited by 18
Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization
Tang, H., Gao, L., Wu, Z., Meng, F., Zhao, X., Shao, Y., Hou, G., Du, X., & Qin, F. X.-F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836232 · Cited by 16
Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
Verkhivker, G. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062928 · Cited by 17
Nanomechanical assay for ultrasensitive and rapid detection of SARS-CoV-2 based on peptide nucleic acid
Wang, Y., Yan, T., Mei, K., Rao, D., Wu, W., Chen, Y., Peng, Y., Wang, J., Wu, S., & Zhang, Q. (2022) · Nano Research · doi:10.1007/s12274-022-4333-3 · Cited by 18
The nervous system during COVID ‐19: Caught in the crossfire
Natale, N. R., Lukens, J. R., & Petri, W. A. (2022) · Immunological Reviews · doi:10.1111/imr.13114 · Cited by 19
Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants
Cuypers, L., Dellicour, S., Hong, S. L., Potter, B. I., Verhasselt, B., Vereecke, N., Lambrechts, L., Durkin, K., Bours, V., Klamer, S., et al. (2022) · Viruses · doi:10.3390/v14102301 · Cited by 17
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
Xia, H., Yeung, J., Kalveram, B., Bills, C. J., Chen, J. Y.-C., Kurhade, C., Zou, J., Widen, S. G., Mann, B. R., Kondor, R. J. G., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2161422 · Cited by 17
Self-citation
SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
Yu, S., Hu, H., Ai, Q., Bai, R., Ma, K., Zhou, M., & Wang, S. (2023) · Viruses · doi:10.3390/v15030639 · Cited by 20
SARS-CoV-2 spike variants differ in their allosteric responses to linoleic acid
Oliveira, A. S. F., Shoemark, D. K., Davidson, A. D., Berger, I., Schaffitzel, C., & Mulholland, A. J. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad021 · Cited by 18
Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages
Qing, E., & Gallagher, T. (2023) · mBio · doi:10.1128/mbio.00171-23 · Cited by 17
COVID-19 mutations: An overview
Sarkar, M. S., & Madabhavi, I. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i3.89761 · Cited by 22
Initial Insights Into the Genetic Epidemiology of SARS-CoV-2 Isolates From Kerala Suggest Local Spread From Limited Introductions
Radhakrishnan, C., Divakar, M. K., Jain, A. K., Viswanathan, P., Bhoyar, R. C., Jolly, B., Imran, M., Sharma, D., Rophina, M., Ranjan, G., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.630542 · Cited by 16
Vaccine against COVID-19
Picazo, J. J. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/085.2021 · Cited by 22
Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater
Avgeris, M., Adamopoulos, P. G., Galani, A., Xagorari, M., Gourgiotis, D., Trougakos, I. P., Voulgaris, Ν., Dimopoulos, M. A., Τhomaidis, Ν. S., & Scorilas, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168498 · Cited by 17
Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations
Verkhivker, G. M., Agajanian, S., Kassab, R., & Krishnan, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084376 · Cited by 18
Structure-function investigation of a new VUI-202012/01 SARS-CoV-2 variantPreprint
Singh, J., Ehtesham, N. Z., Rahman, S. A., & Hasnain, S. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.01.425028 · Cited by 17
S:D614G and S:H655Y are Gateway Mutations that Act Epistatically to Promote SARS-CoV-2 Variant FitnessPreprint
Yurkovetskiy, L., Egri, S. B., Kurhade, C., Díaz-Salinas, M. A., Jaimes, J. A., Nyalile, T., Xie, X., Choudhary, M. C., Dauphin, A., Li, J. Z., et al. (2023) · SSRN Electronic Journal · doi:10.1101/2023.03.30.535005 · Cited by 18
Self-citation
European context of the diversity and phylogenetic position of SARS-CoV-2 sequences from Polish COVID-19 patients
Hryhorowicz, S., Ustaszewski, A., Kaczmarek-Ryś, M., Lis, E., Witt, M., Pławski, A., & Ziętkiewicz, E. (2021) · Journal of Applied Genetics · doi:10.1007/s13353-020-00603-2 · Cited by 15
In silico characterization of mutations circulating in SARS-CoV-2 structural proteins
Periwal, N., Rathod, S. B., Pal, R., Sharma, P., Nebhnani, L., Barnwal, R. P., Arora, P., Srivastava, K. R., & Sood, V. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1908170 · Cited by 16
Fast SARS-CoV-2 Variant Detection Using Snapback Primer High-Resolution Melting
Lownik, J. C., Farrar, J. S., Way, G. W., McKay, A., Roychoudhury, P., Greninger, A. L., & Martin, R. (2021) · Diagnostics · doi:10.3390/diagnostics11101788 · Cited by 16
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Delshad, M., Sanaei, M., Pourbagheri‐Sigaroodi, A., & Bashash, D. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109128 · Cited by 18
Tracking contemporary microbial evolution in a changing ocean
Brennan, G. L., & Logares, R. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.09.001 · Cited by 15
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates
Seenappa, L. M., Jakubowski, A., Steinbuck, M. P., Palmer, E., Haqq, C. M., Carter, C., Fontenot, J. A., Villinger, F. J., McNeil, L. K., & DeMuth, P. C. (2022) · npj Vaccines · doi:10.1038/s41541-022-00560-3 · Cited by 16
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
Wang, Z., An, J., Liu, K., Yü, P., Fang, X. D., Li, J., Zhu, H., Zhu, Q., Huang, C., Zhang, C., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00571-0 · Cited by 15
Self-citation
More or less deadly? A mathematical model that predicts SARS-CoV-2 evolutionary direction
Xu, Z., Wei, D., Zeng, Q.-C., Zhang, H.-M., Sun, Y.-H., & Demongeot, J. (2023) · Comput. Biol. Medicine · doi:10.1016/j.compbiomed.2022.106510 · Cited by 16
Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
Li, M., Du, J., Liu, W., Li, Z., Lv, F., Hu, C., Dai, Y., Zhang, X., Zhang, Z., Liu, G., et al. (2023) · The ISME Journal · doi:10.1038/s41396-023-01368-2 · Cited by 18
Self-citation
Interspecies transmission of SARS CoV-2 with special emphasis on viral mutations and ACE-2 receptor homology roles
Hamdy, M. E., El‐Deeb, A. H., Hagag, N. M., Shahein, M. A., Alaidi, O., & Hussein, H. A. (2023) · International Journal of Veterinary Science and Medicine · doi:10.1080/23144599.2023.2222981 · Cited by 17
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia
Meganck, R. M., Edwards, C. E., Mallory, M. L., Lee, R. E., Dang, H., Bailey, A. B., Wykoff, J. A., Gallant, S. C., Zhu, D. R., Yount, B. L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114076 · Cited by 17
Serial cell culture passaging in vitro led to complete attenuation and changes in the characteristic features of a virulent porcine deltacoronavirus strain
Zhang, L., Yu, R., Wang, L., Zhang, Z., Lu, Y., Zhou, P., Wang, Y., Guo, H., Pan, L., & Liu, X. (2024) · Journal of Virology · doi:10.1128/jvi.00645-24 · Cited by 16
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Roederer, A. L., Cao, Y., Denis, K. S., Sheehan, M. L., Li, C. J., Lam, E. C., Gregory, D. J., Poznansky, M. C., Iafrate, A. J., Canaday, D. H., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101850 · Cited by 18
SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids
Trevisan, M., Riccetti, S., Sinigaglia, A., & Barzon, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052356 · Cited by 16
Genomic Epidemiology of SARS-CoV-2 in Pakistan
Song, S., Li, C., Kang, L., Tian, D., Badar, N., Ma, W., Zhao, S., Jiang, X., Wang, C., Sun, Y., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.08.007 · Cited by 15
Evolutionary insights into the furin cleavage sites of SARS-CoV-2 variants from humans and animals
Nagy, A., Basiouni, S., Parvin, R., Hafez, H. M., & Shehata, A. A. (2021) · Archives of Virology · doi:10.1007/s00705-021-05166-z · Cited by 16
SARS-CoV-2 receptor-binding mutations and antibody contact sites
Mejdani, M., Haddadi, K., Pham, C., & Mahadevan, R. (2021) · Antibody Therapeutics · doi:10.1093/abt/tbab015 · Cited by 17
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
Leach, A., Ilca, F. T., Akbar, Z., Ferrari, M., Bentley, E. M., Mattiuzzo, G., Onuoha, S. C., Miller, A., Ali, H., & Rabbitts, T. H. (2021) · Antiviral Research · doi:10.1016/j.antiviral.2021.105147 · Cited by 16

Authors: Plante, J. A., Liu, Y., Liu, J., Xia, H., Johnson, B. A., Lokugamage, K. G., Zhang, X., Muruato, A. E., Zou, J., Fontes-Garfias, C. R., Mirchandani, D., Scharton, D., Bilello, J. P., Ku, Z., An, Z., Kalveram, B., Freiberg, A. N., Menachery, V. D., Xie, X., Plante, K. S., Weaver, S. C., & Shi, P.-Y.
Affiliations: The University of Texas Medical Branch at Galveston (US)
Gilead Sciences (United States) (US)
Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
Corresponding author: Xie, Xuping
Plante, Kenneth S.
Weaver, Scott C.
Shi, Pei-Yong
ORCID: Plante, Jessica A.
Liu, Jianying
Xia, Hongjie
Johnson, Bryan A.
Zhang, Xianwen
Zou, Jing
Fontes-Garfias, Camila R.
Scharton, Dionna
Bilello, John P.
Ku, Zhiqiang
An, Zhiqiang
Freiberg, Alexander N.
Menachery, Vineet D.
Xie, Xuping
Plante, Kenneth S.
Weaver, Scott C.
Shi, Pei-Yong
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2020-10-26
Volume: 592
Issue: 7852
Pages: 116-121
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/s41586-020-2895-3
PMC: PMC8158177
OpenAlex: W3093768302
Cited by: 1,558
References: 37
Citations by year: 2026: 37 · 2025: 73 · 2024: 120 · 2023: 174 · 2022: 427 · 2021: 670 · 2020: 55
FWCI: 43.60
Type: journal article
Language: en
Update notices: correction (2021-06-15)
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
PubMed Central (submittedVersion, cc-by-nc-nd)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Amon G. Carter Foundation
John S. Dunn Foundation (AI145617)
University of Texas System
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (AI134907)
National Institutes of Health (AG049042, TL1TR001440, AI145617, AI142759, UL1TR001439)
National Institute on Aging (AI142759, AG049042, R00AG049092)
National Institute of Allergy and Infectious Diseases (R43AI145617, AI142759, R24AI120942, R01AI134907, R21AI145400, U01AI151801, U19AI142759, R01AI153602, AI153602, AG049042, AI134907, AI145617, UC7AI094660)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: SARS-CoV-2, viral fitness, viral replication, upper respiratory tract infection, virus transmission, neutralizing antibodies, vaccine efficacy, hamster model, lung epithelial cells, therapeutic antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spike mutation D614G alters SARS-CoV-2 fitness

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks